J. Taylor

发表

Selective stimulation of somatostatin receptor subtypes: differential effects on Ras/MAP kinase pathway and cell proliferation in human neuroblastoma cells

M. Cattaneo, J. Taylor, M. Culler, 2000, FEBS letters.

In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue.

A. Bogdén, J. Taylor, D. Coy, 1988, Biochemical and biophysical research communications.

The effect of ozone fumigation on the biogenic volatile organic compounds (BVOCs) emitted from Brassica napus above- and below-ground

C. N. Hewitt, J. Taylor, G. Wohlfahrt, 2018, PloS one.

Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.

S. Melmed, I. Shimon, J. Taylor, 1997, The Journal of clinical investigation.

Structural requirements at the N-terminus of urotensin II octapeptides

J. Taylor, D. Coy, W. Rossowski, 2002, Peptides.

Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration.

A. Bogdén, J. Taylor, D. Coy, 1990, Cancer research.

Human small cell lung cancer cells express high affinity naloxone-insensitive [125I]-endorphin binding sites.

J. Taylor, 1994, Life sciences.

Transepithelial chemotaxis of rat peritoneal exudate cells.

N. Simmons, J. Taylor, J. D. Walker, 1983, British journal of experimental pathology.

Metamizol potentiates morphine effects on visceral pain and evoked c-Fos immunoreactivity in spinal cord.

I. Fernaud, J. Taylor, B. Mellström, 1998, European journal of pharmacology.

Highly potent cyclic disulfide antagonists of somatostatin.

J. Taylor, D. Coy, S. Hocart, 1999, Journal of medicinal chemistry.

Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies.

W. Mcbride, D. Wilson, J. Taylor, 1996, Journal of medicinal chemistry.

Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.

G. Bell, J. Taylor, D. Coy, 1993, Molecular pharmacology.

In vitro antiangiogenic activity of selective somatostatin subtype‐1 receptor agonists

R. Danesi, J. Taylor, M. Culler, 2007, European journal of clinical investigation.

Classification and nomenclature of somatostatin receptors.

D. Hoyer, G. Bell, J. Taylor, 1995, Trends in pharmacological sciences.

Somatostatin analogues and small-cell lung carcinoma.

J. Taylor, 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Binding of Neuromediators to Their Receptors in Rat Brain

J. Taylor, 1988 .

Purification and properties of chicken growth hormone and the development of a homologous radioimmunoassay.

J. Taylor, R. A. Long, J. Rodkey, 1984, General and comparative endocrinology.

Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist.

J. Taylor, D. Coy, S. Hocart, 2001, Journal of medicinal chemistry.

Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.

R. Jensen, J. Taylor, D. Coy, 1998, European journal of pharmacology.

Differential regulation of insulin-like growth factor-II receptors in rat hepatocytes and hepatoma cells.

R. Baxter, J. Taylor, C. Scott, 1988, Biochemical and biophysical research communications.

Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells.

I. Shimon, H. Rubinfeld, J. Taylor, 2004, European journal of endocrinology.

Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP.

J. Taylor, D. Coy, T. Moran, 1996, The American journal of physiology.

Characterization of bombesin binding sites in the rat stomach.

R. Jensen, J. Taylor, D. Coy, 1997, European journal of pharmacology.

Caudal hindbrain neuromedin B-preferring receptors participate in the control of food intake.

J. Taylor, D. Coy, T. Moran, 1997, The American journal of physiology.

Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin.

C. Mobbs, J. Taylor, T. Mizuno, 1998, Endocrinology.

Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.

S. Melmed, Xinmin Yan, I. Shimon, 1997, The Journal of clinical investigation.

Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment.

D. Cocchi, J. Taylor, M. Culler, 2002, Endocrinology.

Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells.

J. Taylor, M. Culler, A. Barlier, 2002, The Journal of clinical endocrinology and metabolism.

Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.

R. Jensen, J. Taylor, D. Coy, 1993, Molecular pharmacology.

Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells

T. Moody, J. Taylor, J. Moreau, 1991, Peptides.

Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5.

D. Pipeleers, J. Taylor, M. Culler, 1999, Biochemical pharmacology.

The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro.

J. Taylor, M. Culler, M. Pawlikowski, 2006, Life sciences.

Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.

J. Taylor, M. Culler, H. Dufour, 2005, European journal of endocrinology.

BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.

J. Taylor, M. Culler, A. Barlier, 2005, Journal of endocrinological investigation.

In vivo and in vitro stimulation of growth hormone release in chickens by synthetic human pancreatic growth hormone releasing factor (hpGRFs).

J. Taylor, F. Leung, 1983, Endocrinology.

Novel urotensin II (UII) antagonists point to multiple receptor involvement in UII bioactivity

J. Taylor, D. Coy, S. Hocart, 2000, Regulatory Peptides.

Desensitization of histamine H1 receptor-mediated cyclic GMP formation in mouse neuroblastoma cells.

J. Taylor, E. Richelson, 1979, Molecular pharmacology.

Bradykinin‐antagonists: Therapeutic perspectives

F. V. Defeudis, J. Taylor, J. Moreau, 1989 .

Four assay methods for glycated hemoglobin compared as screening tests for diabetes mellitus: the Islington Diabetes Survey.

C. Jackson, J. Taylor, J. Yudkin, 1988, Clinical chemistry.

Short-Term Effect of a 75 g Oral Glucose Load on Glycohaemoglobin Levels

J S Yudkin, C. Jackson, J. Taylor, 1987, Annals of clinical biochemistry.

Somatostatin receptor subtype gene expression in human and rodent tumors.

J. Taylor, P. Eden, John E. Taylor, 1993, Life sciences.

Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition.

G. Gores, N. LaRusso, D. Nagorney, 1995, Gastroenterology.

Response of human lung tumor xenografts to treatment with a somatostatin analogue (Somatuline).

A. Bogdén, J. Taylor, D. Coy, 1990, Cancer research.

N-Methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity.

J. Taylor, D. Coy, S. Hocart, 2001, Journal of medicinal chemistry.

Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles.

J. Taylor, D. Krupa, M. Fisher, 1994, The Journal of endocrinology.

Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles.

J. Taylor, D. Krupa, G. Hickey, 1994, Endocrinology.

Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells.

R. Jensen, L. Wang, J. Taylor, 1990, Biochemistry.

High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69).

J. Taylor, D. Coy, J. Moreau, 1988, Life sciences.

Comparison of receptors for insulin-like growth factor II from various rat tissues.

R. Baxter, J. Taylor, C. Scott, 1987, The Journal of endocrinology.

Synthesis, Structure, and Antagonistic Properties of des-Asn29[d-Trp28,32]NPY(27–36)

J. Fischer, J. Taylor, L. Kar, 1996, Peptides.

Long-term regulation of muscarinic acetylcholine receptors on cultured nerve cells.

J. Taylor, E. Richelson, E. El-Fakanany, 1979, Life sciences.

Synthesis and biological evaluation of pNPY fragments.

E. Kaiser, J. Taylor, W. Danho, 2009, International journal of peptide and protein research.

Pharmacological profiles of two bombesin analogues in cells transfected with human neuromedin B receptors.

J. Taylor, A. Cowan, J. Daniel, 1996, European journal of pharmacology.

Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity.

R. Jensen, J. Taylor, D. Coy, 1988, The Journal of biological chemistry.

Novel somatostatin analogs for the treatment of acromegaly and cancer exhibit improved in vivo stability and distribution.

J. Taylor, T. Davis, J. Dong, 1998, The Journal of pharmacology and experimental therapeutics.

Potent antagonists of somatostatin: synthesis and biology.

J. Taylor, D. Coy, S. Hocart, 1998, Journal of medicinal chemistry.

Receptor-specific somatostatin analogs: correlations with biological activity.

J. Taylor, D. Coy, David H. Coy, 1996, Metabolism: clinical and experimental.

Small peptides and nerve growth: Therapeutic implications

F. V. Defeudis, J. Taylor, J. Moreau, 1987 .

des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists.

R. Jensen, L. Wang, J. Taylor, 1990, The Journal of biological chemistry.

Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.

J. Taylor, D. Coy, J. Moreau, 1989, Peptide research.

Synthesis and binding potencies of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues

J. Taylor, B. Morgan, John E. Taylor, 1999, Journal of peptide science : an official publication of the European Peptide Society.

Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.

R. Jensen, L. Wang, J. Taylor, 1989, The Journal of biological chemistry.

Effects of dietary thyroid hormones on growth, plasma T3 and T4, and growth hormone in normal and hypothyroid chickens.

J. Taylor, F. Leung, A. V. Van Iderstine, 1985, General and comparative endocrinology.

Development of an assay for the simultaneous determination of sildenafil (Viagra) and its metabolite (UK-103,320) using automated sequential trace enrichment of dialysates and high-performance liquid chromatography.

J. Taylor, P. Baker, J. Cooper, 1997, Journal of chromatography. B, Biomedical sciences and applications.

3′,5′-Cyclic nucleotide phosphodiesterase 11A: localization in human tissues

J. Taylor, K. Loughney, V. Florio, 2005, International Journal of Impotence Research.

Purification and characterization of avian dopamine beta-hydroxylase.

J. Taylor, R. Tolman, R. A. Long, 1981, Biochemistry.

Simultaneous determination of lamotrigine and its glucuronide and methylated metabolites in human plasma by automated sequential trace enrichment of dialysates and gradient high-performance liquid chromatography.

J. Taylor, J. Cooper, N. Shearsby, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Alternative bridging groups for proline in endothelin pentapeptide receptor antagonists

J. Taylor, D. Coy, S. Hocart, 1994 .

Purified chicken growth hormone (GH) and a human pancreatic GH-releasing hormone increase body weight gain in chickens.

J. Taylor, F. Leung, A. V. Van Iderstine, 1986, Endocrinology.

Potent interaction between thyrotropin releasing hormone (TRH) and human pancreatic growth hormone releasing factor (hpGRF) in stimulating chicken growth hormone (cGH) in vivo: Hypothalamic noradrenergic mediation in TRH stimulation of cGH release

J. Taylor, F. Leung, C. Ball, 1985 .

Brain-derived neurotrophic factor promotes bovine oocyte cytoplasmic competence for embryo development.

J. Gardner, J. Taylor, R. Anderson, 2005, Reproduction.

Bis(31/31') ([CYS(31), Trp(32), Nva(34)] NPY-(31-36)): a specific NPY Y-1 receptor antagonist.

J. Fischer, J. Taylor, W. Chance, 1996, Journal of medicinal chemistry.

Specific neurotoxin lesions of median raphe serotonergic neurons disrupt maternal behavior in the lactating rat.

J. Taylor, Y. Tizabi, R. Kumar, 1983, Endocrinology.

High-affinity binding of [3H]doxepin to histamine H1-receptors in rat brain: possible identification of a subclass of histamine H1-receptors.

J. Taylor, E. Richelson, 1982, European journal of pharmacology.

High affinity binding of tricyclic antidepressants to histamine H1-receptors: fact and artifact.

J. Taylor, E. Richelson, J E Taylor, 1980, European journal of pharmacology.

Desensitization of histamine H1 receptors on mouse neuroblastoma cells

J. Taylor, E. Richelson, 1978 .

Differences between pig tissues in the expression of major transplantation antigens: possible relevance for organ allografts

J. Taylor, H. Davies, M. Daniel, 1976, The Journal of experimental medicine.

Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT.

J. Taylor, M. Culler, D. Piccin, 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt.

J. Taylor, M. Culler, F. Tagliati, 2001, The Journal of clinical endocrinology and metabolism.

Activity of a novel nonpeptidyl growth hormone secretagogue, L-700,653, in swine.

J. Taylor, S. Feighner, F. Marsilio, 1995, Endocrinology.

Inhibition of [3H]spiperone binding to 5-HT2 receptors of rat cerebral cortex by the calcium antagonists verapamil and D600.

F. V. Defeudis, J. Taylor, F. Defeudis, 1984, European journal of pharmacology.

Synthesis and binding potencies of cyclic hexapeptide analogs of somatostatin incorporating acidic and basic peptoid residues.

J. Taylor, B. Morgan, M. Goodman, 1999, The journal of peptide research : official journal of the American Peptide Society.

Somatostatin receptor subtypes: targeting functional and therapeutic specificity.

J. Taylor, M. Culler, J. Moreau, 2002, Annales d'endocrinologie.

Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas

D. Nass, I. Shimon, H. Rubinfeld, 2008, Molecular and Cellular Endocrinology.

Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues

J. Taylor, M. Culler, M. Stridsberg, 2007, Regulatory Peptides.

Improved analogs and novel delivery systems for somatostatin octapeptides.

J. Taylor, F. Ignatious, B. Morgan, 1996, Metabolism: clinical and experimental.

Blockade of feeding inhibition by neuromedin B using a selective receptor antagonist.

J. Taylor, D. Coy, T. Moran, 1994, European journal of pharmacology.

Somatostatin (SSTR2) receptors mediate phospholipase C-independent Ca2+ mobilization in rat AR42J pancreas cells.

J. Taylor, 1995, Biochemical and biophysical research communications.

Dorsal raphe-hypothalamic projections provide the stimulatory serotonergic input to suckling-induced prolactin release.

J. Taylor, V. Massari, A. Barofsky, 1983, Endocrinology.

An electronic nose employing dual-channel odour separation columns with large chemosensor arrays for advanced odour discrimination

James A. Covington, Julian W. Gardner, F. K. Che Harun, 2009 .

Syntheses and biological activities of sandostatin analogs containing stereochemical changes in positions 6 or 8.

D. Hoyer, J. Taylor, B. Morgan, 2000, Biopolymers.

[Neuromediator binding to receptors in the rat brain. The effect of chronic administration of Ginkgo biloba extract].

J. Taylor, 1986, Presse medicale.

Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists

T. Moody, J. Staley, J. Taylor, 1992, Peptides.

Bombesin receptor antagonists differentiate receptor subtypes in rat brain.

R. Jensen, J. Taylor, D. Coy, 1993, European journal of pharmacology.

Determination of eletriptan in plasma and saliva using automated sequential trace enrichment of dialysate and high-performance liquid chromatography.

J. Taylor, J. Cooper, D. Muirhead, 1999, Journal of pharmaceutical and biomedical analysis.

[Des-Met14]Bombesin analogues function as small cell lung cancer bombesin receptor antagonists

J. Staley, J. Taylor, D. Coy, 1991, Peptides.

[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.

T. Moody, J. Staley, J. Mulshine, 1991, Cancer research.

Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine.

J. Fischer, D. Mcfadden, J. Taylor, 2000, Journal of medicinal chemistry.

Thyrotropin-releasing hormone stimulates body weight gain and increases thyroid hormones and growth hormone in plasma of cockerels.

J. Taylor, F. Leung, A. V. Van Iderstine, 1984, Endocrinology.

Effects of Dietary Thyroid Hormones on Growth and Serum T3, T4, and Growth Hormone in Sex-Linked Dwarf Chickens

J. Taylor, F. Leung, A. V. Van Iderstine, 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.

O. Ziv, D. Hoyer, J. Taylor, 1998, Journal of medicinal chemistry.

Applying Convolution‐Based Processing Methods To A Dual‐Channel, Large Array Artificial Olfactory Mucosa

James A. Covington, Julian W. Gardner, F. K. Che Harun, 2009 .

Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein in the rat.

J. Taylor, M. Chorev, T. Davis, 1995, The Journal of pharmacology and experimental therapeutics.